Typed Study: Natalizumab for the Treatment of Pediatric-Onset Multiple Sclerosis in Portugal
AuthID
P-00T-NAG
P-00T-NAG
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service